[1]肾癌pd-1/pd-l1的作用及抗体治疗的研究现状 [2]ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors [3]三阴性乳腺癌患者pd-1/pd-l1通路表达改变及临床意义 [4]Tumor-associated macrophages regulate the function of cytotoxic T lymphocyte through PD-1/PD-L1 pathway in multiple myeloma [5]局部晚期食管癌免疫治疗的现状及前景 [6]PI3K/mTOR Pathway Alterations May Mediate PD-1/PD-L1 Blockade Resistance in Non-Small Cell Lung Cancer [7]pd-1/pd-l1免疫检查点抑制剂相关甲状腺功能减退症的诊断及处理 [8]A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer [9]肾透明细胞癌及肾嗜酸细胞腺瘤的多层螺旋CT分析与鉴别 [10]PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma